Exact Therapeutics AS Market Cap ($4.66 Million)
Market Cap & Net Worth: Exact Therapeutics AS (EXTX)
Exact Therapeutics AS market cap. Exact Therapeutics AS (OL:EXTX) has a market capitalization of $4.66 Million (Nkr44.28 Million) as of November 1, 2026. Listed on the OL stock exchange, this Norway-based company holds position #28664 globally and #257 in its home market, demonstrating a 7.69% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Exact Therapeutics AS's stock price Nkr0.70 by its total outstanding shares 63263347 (63.26 Million). Also see how efficiently does Exact Therapeutics AS generate cash for how efficiently the company converts equity into cash flow.
Exact Therapeutics AS Market Cap History (2020–2026)
Exact Therapeutics AS market cap history from 2020 to 2026. Data shows change from $196.39 Million to $4.66 Million (-45.75% CAGR). Check Exact Therapeutics AS stock quote for real-time trading data and today's change.
Exact Therapeutics AS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Exact Therapeutics AS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore EXTX shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of EXTX by Market Capitalization
Companies near Exact Therapeutics AS in the global market cap rankings as of November 1, 2026. Also see Exact Therapeutics AS total assets for a full breakdown of the balance sheet.
Key companies related to Exact Therapeutics AS by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #182 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $558.88 |
| #371 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $927.89 |
| #412 | CSL Ltd | AU:CSL | $68.91 Billion | AU$200.73 |
| #495 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $221.72 |
Market Capitalization of Exact Therapeutics AS (2020–2026)
Market capitalization of Exact Therapeutics AS from 2020 to today. Between 2020 and today, Exact Therapeutics AS's market cap moved from $196.39 Million to $ 4.66 Million, with a yearly change of -45.75%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Nkr4.66 Million | -49.28% |
| 2025 | Nkr9.19 Million | -63.30% |
| 2024 | Nkr25.03 Million | -68.67% |
| 2023 | Nkr79.89 Million | 0.00% |
| 2022 | Nkr79.89 Million | -31.03% |
| 2021 | Nkr115.83 Million | -41.02% |
| 2020 | Nkr196.39 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Exact Therapeutics AS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.66 Million USD |
| MoneyControl | $4.66 Million USD |
| MarketWatch | $4.66 Million USD |
| marketcap.company | $4.66 Million USD |
| Reuters | $4.66 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Exact Therapeutics AS
EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT). The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various indications, including within oncology and brain diseases. … Read more